Jun Zhou

Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano et al. · Cancer Immunology Research · 2014 · 595 citations · Full text

Immunology, Immunoediting, Pathology +16

The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition

Xiaofeng Jiang, Jun Zhou, Anita Giobbie‐Hurder et al. · Clinical Cancer Research · 2012 · 464 citations · Full text

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein et al. · Cancer Immunology Research · 2015 · 422 citations · Full text

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade

Jun Zhou, Kathleen M. Mahoney, Anita Giobbie‐Hurder et al. · Cancer Immunology Research · 2017 · 356 citations · Full text

The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial

Lu Ma, Xin Hu, Lili Song et al. · The Lancet · 2023 · 312 citations · Full text